Adaptive Evolution of Staphylococcus aureus during Chronic Endobronchial Infection of a Cystic Fibrosis Patient by McAdam, P.R. et al.
  
 
 
 
Edinburgh Research Explorer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Adaptive Evolution of Staphylococcus aureus during Chronic
Endobronchial Infection of a Cystic Fibrosis Patient
Citation for published version:
McAdam, PR, Holmes, A, Templeton, KE & Fitzgerald, JR 2011, 'Adaptive Evolution of Staphylococcus
aureus during Chronic Endobronchial Infection of a Cystic Fibrosis Patient' PLoS One, vol. 6, no. 9, pp.
e24301. DOI: 10.1371/journal.pone.0024301
Digital Object Identifier (DOI):
10.1371/journal.pone.0024301
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:
Publisher's PDF, also known as Version of record
Published In:
PLoS One
Publisher Rights Statement:
This is an open-access article distributed under the terms of the Creative Commons Attribution License, which
permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are
credited.
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 05. Apr. 2019
Adaptive Evolution of Staphylococcus aureus during
Chronic Endobronchial Infection of a Cystic Fibrosis
Patient
Paul R. McAdam1, Anne Holmes1,2, Kate E. Templeton2, J. Ross Fitzgerald1*
1 The Roslin Institute and Centre for Infectious Diseases, Royal (Dick) School of Veterinary Studies, University of Edinburgh, Easter Bush, Midlothian, United Kingdom,
2Microbiology, Royal Infirmary of Edinburgh, Edinburgh, United Kingdom
Abstract
The molecular adaptation of Staphylococcus aureus to its host during chronic infection is not well understood. Comparative
genome sequencing of 3 S. aureus isolates obtained sequentially over 26 months from the airways of a cystic fibrosis
patient, revealed variation in phage content, and genetic polymorphisms in genes which influence antibiotic resistance, and
global regulation of virulence. The majority of polymorphisms were isolate-specific suggesting the existence of an
heterogeneous infecting population that evolved from a single infecting strain of S. aureus. The genetic variation identified
correlated with differences in growth rate, hemolytic activity, and antibiotic sensitivity, implying a profound effect on the
ecology of S. aureus. In particular, a high frequency of mutations in loci associated with the alternate transcription factor
SigB, were observed. The identification of genes under diversifying selection during long-term infection may inform the
design of novel therapeutics for the control of refractory chronic infections.
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Introduction
Staphylococcus aureus causes chronic, recurrent endobronchial
infections of patients with cystic fibrosis (CF) during childhood
[1,2]. Impaired mucociliary clearance, insufficient aeration of the
paranasal sinuses and nasal polyps, along with frequent hospital
visits mean CF patients are at particularly high risk of S. aureus
infections [3,4]. In CF patients, it is the oropharynx rather than
the anterior nares which is the predominant site of S. aureus
infection and persistence [5] and the upper airways have been
identified as a reservoir allowing for recurrent infection of the
lower airways by the same clone [6]. Further, longitudinal studies
have shown that isolates belonging to the same lineage are
repeatedly recovered from most CF patients, indicating chronic
infection with a single strain [3,7]. During chronic infection, S.
aureus is subjected to numerous selective pressures resulting from
antibiotic interventions, the host immune system and co-infection
of the airways with other microorganisms [8]. Adaptive strategies
of S. aureus are thought to involve the emergence of antibiotic-
resistant, low-virulence, persistent phenotypes [1,9]. Of note, a
switch to small colony variants (SCV) is often observed in
persistent infections and is associated with higher levels of
resistance to antibiotics [9,10,11,12]. In addition, hyper-mutable
S. aureus strains with a defective DNA mismatch repair system have
been isolated from CF infections which promote adaptation to
encountered selective pressures [13,14,15]. However, the molec-
ular basis for the adaptation of S. aureus to the CF airways is not
well understood and lags behind research into the CF pathogen
Pseudomonas aeruginosa [16]. For example, a comparative genomic
study revealed evidence for selection acting across the whole P.
aeruginosa genome, reflected in an adapted virulence phenotype
with loss of function of factors required for acute infection but
enhanced ability to cause chronic inflammation [17]. Previous
genome-scale analyses of S. aureus evolution during infection
revealed that most mutations were the result of the strong selective
pressure of antibacterial chemotherapy but may also be associated
with promoting persistence [18,19].
Here, we performed a comparative genomic analysis of
sequential S. aureus isolates from a single CF patient to investigate
in vivo adaptive diversification. The genetic and phenotypic
variation identified among the isolates indicates an adapting
infecting population which is genetically and phenotypically
heterogenous. Overall, the study provides for the first time, a
genome-wide, high resolution insight into the evolution of S. aureus
during chronic infection of the cystic fibrosis airways.
Methods
Bacteria, growth conditions and phenotypic analysis
Sequential S. aureus isolates ED83, ED84 (11 months) and ED86
(26 months) were obtained from the sputum of a CF patient over a
26-month period and were previously characterized by pulse field
gel electrophoresis (PFGE), capsule- and phage-typing to infer the
clonal relatedness of the isolates [7]. S. aureus isolates were cultured
in Tryptic Soy Broth (TSB), chemical defined media (CDM) and
CDM lacking threonine as previously described [20]. Hemolytic
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activity was assessed after overnight culture of isolates at 37uC on
tryptic soy agar (TSA) containing sheep blood. Sensitivity to
antibiotics including Penicillin, Oxacillin, Gentamycin, Kanamy-
cin, Tobramycin, Ciprofloxacin, Erythromycin, Clindamycin,
Linezolid, Teicoplanin, Vancomycin, Tetracycline, Tigecycline,
Nitrofurantoin, Fusidic acid, Mupiricin, Chloramphenical, Rifam-
picin, and Trimethoprim, was carried out using the Vitek 2 system
(bioMe´rieux, Basingstoke, UK).
Genome sequencing and analysis
Whole-genome sequencing was performed using the Illumina
Genome Analyzer II platform (36 base-pair paired end (ED83) or
single end reads (ED84 and ED86). High quality reads were
aligned against the MRSA252 genome (accession number
NC_002952) using Maq v0.7.1 (http://maq.sourceforge.net). A
mean coverage of 34.2 was achieved (range 25.7–44.1). Point
mutations and short indels were identified using Maq and
Novoalign (http://www.novocraft.com/main/index.php), and
confirmed by Sanger sequencing. Sequence reads unmapped to
the reference sequence were assembled de novo using the program
Velvet v0.7.63 (http://www.ebi.ac.uk/˜zerbino/velvet), and pro-
tein-coding regions were identified through a BLASTx search
against the NCBI non-redundant protein database. Comparative
genomic analysis was performed using BRIG v0.71 (http://
sourceforge. net/projects/brig) and IGV v1.5.06 (http://www.
broadinstitute.org/software/igv) to identify differences in gene
content between the isolates. Draft genomes have been deposited
in the NCBI SRA database (accession number SRA038522.2).
Phylogenetic and statistical analysis
Phylogenetic reconstruction was performed with RAxML v7.2.6
(http://wwwkaramer.in.tum.de/exelixix/software.html) for all
sites in the core genome, using a GTR model of nucleotide
substitution with the gamma model of rate heterogeneity. Support
for nodes was assessed using 1000 bootstrap replicates. Loci
accumulating a greater number of mutations per site in
comparison to the rest of the genome were identified by a one-
tailed Welch’s T-test.
Results and Discussion
In a previous study, CF patients with persistent colonization of
the airways by single S. aureus clones were identified by a
combination of PFGE, capsule- and phage-typing of sequential
isolates [7]. In order to examine the microevolution of S. aureus
during chronic infection of the CF airways, the genomes of 3 of the
sequential isolates obtained over 26 months from the airways of a
persistently colonized CF patient were sequenced. Genome
sequence analysis revealed each of the 3 isolates to be of multi-
locus sequence type 30 (ST30), a globally successful epidemic
clone, but a total of 23 point mutations and 15 indels were
identified among the 3 isolates, including 31 intragenic and 6
intergenic polymorphisms (Table S1). Phylogenetic analysis of the
3 sequential CF isolates in comparison to 5 representative strains
of the same clonal complex (CC30) based on core genome point
mutations indicates that the 3 CF isolates form a very narrow,
distinct clade within the CC30 tree, consistent with their evolution
from a single infecting progenitor strain (Fig. 1). Of note, all 23
point mutations and 14 of the 15 indels identified among the 3
isolates were strain-specific indicating clonal diversification of the
original infecting strain leading to a genetically heterogenous
infecting population (Table S1). Of the 391 polymorphisms (376
point mutations and 15 indels) shared by the core genomes of all 3
isolates compared to the reference genome, none resulted in
pseudogenes, and there were no mutations in the methyl-
mismatch repair system (MutS and MutL) suggesting that the
strains are not hypermutable. The great majority of point
mutations (95.7%) were non-synonymous, consistent with previous
studies that have reported a high ratio of non-synonymous to
synonymous point mutations within clonal complexes, in contrast
to a higher frequency of synonymous point mutations between
clonal complexes [21]. These data support the hypothesis that
mildly deleterious mutations are maintained in the short term.
However, the high proportion of non-synonymous mutations are
likely, at least in part, to be the result of strong selective pressures
that exist in the unique environment of the CF airways. In
particular, we discovered point mutations and indels in genes
influencing global regulation, virulence, metabolism, and antibi-
otic resistance. For example, in the last sequential isolate (ED86), 2
amino acid-altering point mutations were identified in the fusA
gene encoding elongation factor G (EF-G) including a H457Y
amino acid replacement previously demonstrated to confer fusidic
acid resistance [22]. Although the mutation is associated with a
marked impairment in the biological fitness of S. aureus, the growth
phenotype of ED86 compares favorably with that of the fusidic
acid-susceptible isolates ED83 and ED84 in TSB, CDM and
threonine-depleted CDM (Fig. 1), presumably due to a compen-
satory function of the second observed mutation, T187I, as
previously reported for fusidic acid resistance strains of S. aureus
[22]. Consistent with the presence of these mutations, isolate
ED86 was resistant to fusidic acid. All 3 isolates were resistant to
penicillin but were sensitive to each of the other antibiotics tested
(data not shown).
Several of the identified mutations were in genes which may
impact on virulence. For example, the branched chain amino acid
binding pocket of the global regulator CodY [23] is invariant in all
S. aureus genome sequences available in the public databases (data
not shown). The gene encoding CodY in the third sequential
isolate ED86 contains a non-synonymous point mutation resulting
in a M65I amino acid replacement in the wall of the hydrophobic
binding pocket which forms prominent hydrophobic interactions
with the side chains of the branched chain amino acid ligand [24].
We speculate that the observed mutation may affect the function
of CodY, which is a potent repressor of virulence [20,23]. Of note,
the ED86 isolate containing the M65I replacement has increased
growth rate in minimal media deficient in threonine in comparison
to isolates ED83 and ED84 which both contain wild type CodY
alleles, a growth characteristic demonstrated previously for a
CodY S. aureus mutant (Fig. 1)[20].
In addition, multiple, independent indel polymorphisms were
observed in all 3 isolates which would influence expression of SigB,
a regulator of the general stress response which influences the
expression of virulence factors. Specifically, a frameshift mutation
resulting in a sigB pseudogene in strain ED83, a frameshift
mutation in SpoVG, a proposed modulator of SigB activity [25],
and an 18 bp in frame deletion in the rsbU regulator of SigB in
ED84, were identified. Modeling of the ED84 rsbU allele with the
crystal structure of the Bacillus subtilis RsbU protein (PDB accession
number 2J70) suggests that the 18 bp deletion is likely to impair
the phosphatase activity of RsbU (data not shown). In addition,
SpoVG and the histidine kinase ArlS, which have been shown to
impact SigB-dependent capsule formation [25], are affected by a
non-synonymous point mutation and a frameshift insertion
respectively in the ED86 isolate. The parallel evolution of
mutations at SigB-associated loci in the 3 isolates represent a
119-fold increase in mutation rate when compared to the mutation
rate across the whole genome (p,0.05), suggesting that a strong
selective pressure is acting on these loci leading to beneficial
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phenotypes adapted to the environment of the CF airways. Several
previous studies have identified a role for SigB in the development
of SCVs and in the regulation of transcription of virulence factors
during infection of CF patients [9,26,27]. Our data suggest that
there may be selective pressure for attenuation or loss of SigB
expression during long-term infection. In order to further
investigate this phenomenon, we determined the DNA sequence
for SigB-associated loci rsbU, rsbV, rsbW, sigB, spoVG, arlS, and arlR
among a panel of 16 S. aureus isolates from 4 CF patients
persistently colonized with S. aureus [7]. However, only 2 mutations
(non-synonymous substitutions in the spoVG and arlR loci in
different isolates) were observed, and no loss of function mutations
were identified at any of the loci examined (data not shown).
Taken together, these data suggest that the elevated mutation rate
in SigB-associated loci in S. aureus isolates ED83, ED84 and ED86
is related to the genetic background of the strain or to patient-
specific selective pressures, and is not broadly applicable to all CF
S. aureus isolates. Of note, clinical isolates of S. aureus with SigB-
deficiency have been reported previously [28]. Previously, Entenza
and colleagues investigated the role of SigB in a rat model of
infective endocarditis and discovered increased bacterial densities
of SigB-deficient strains after prolonged infective endocarditis
infection suggestive of a selective pressure for reduced SigB activity
during infection [29].
In order to examine the collective functional impact of the
identified polymorphisms we examined hemolytic activity, and
growth of each of the isolates in nutrient-replete and -deplete
conditions. No difference in growth was observed between the 3
isolates in TSB (data not shown) but differences in growth rate
were observed in CDM and CDM deficient in threonine (Fig. 1).
Further, sub-culturing of single colonies of isolates ED83 and
ED86 onto TSA containing sheep erythrocytes resulted in 2
distinct colony sizes which differed in hemolytic activity (large,
hemolytic and small, non-hemolytic) for each isolate revealing an
unstable in vitro phenotype (Fig. 1).
In addition to polymorphisms of the core genome, variation in
the accessory genome of the isolates was observed. Examination of
the genome sequence of isolate ED83 revealed 3 prophages
including a 48.3 kb phage related to wSa2 of MRSA252, a 43.5 kb
b-converting phage encoding the secreted virulence factors
staphylococcus enterotoxin A (SEA) and staphylokinase (SAK),
and a 20.2 kb phage remnant with homology to wNM4 of S. aureus
strain Newman. Comparative genomic analysis indicates that
isolate ED84 has lost the b-converting phage whereas isolate
ED86 lacks the wSa2 homologue. These data indicate that phage
deletion and/or acquisition events occur during S. aureus infection
of the CF airways, consistent with previous findings [30]. By
maintaining phages that encode secreted virulence factors in a
subpopulation of the infecting bacteria, the metabolic costs to the
infecting population as a whole are reduced in nutritionally-
starved niches. Consistent with absence of the b-converting phage,
strain ED84 demonstrated hemolytic activity for sheep erythro-
cytes, indicating the presence of a functional b-toxin gene (Fig. 1).
Overall, the genome-scale identification of polymorphisms
affecting antibiotic resistance, growth, and global regulation of
virulence indicate a profound impact on the ecology of S. aureus
during chronic infection. The identification of loci under selective
pressure during chronic S. aureus infection may indicate novel
therapeutic targets for the control of persistent infections which are
refractory to treatment.
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